Phibro Animal Health Corporation PAHC
Set alert
As of Nov 3, 11:18 AM ET
- YTD
- +2.70%
- 1 year
- -11.53%
- Open
- 38.93
- Prev close
- 38.74
- Mkt cap
- 1.56B
- Vol
- 39.35K
- Avg vol
- 219.17K
- EPS
- 2.43
- P/E
- 15.80
- Div yield
- 1.24%
More statistics
- Low
- 38.14
- High
- 39.53
- Forward P/E
- 10.07
- Beta
- 0.40
- Short ratio
- 4.10
- Inst. own
- 102.94%
- Dividend
- 0.48
- Ex-div date
- Sep 1, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 36.99
- 200-d avg
- 41.26
- 1y target
- 47.00
1D chart
Signals (14)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | 11:04 AM | 14 minutes ago |
| RSI: Oversold | 10:51 AM | 27 minutes ago |
| RSI: Oversold | 10:46 AM | 32 minutes ago |
| SMA: Bearish | 10:44 AM | 34 minutes ago |
| SMA: Bearish | 10:44 AM | 34 minutes ago |
| MACD: Sell Signal | 10:44 AM | 34 minutes ago |
| SMA: Bullish | 10:42 AM | 36 minutes ago |
| SMA: Bullish | 10:42 AM | 36 minutes ago |
| MACD: Buy Signal | 10:42 AM | 36 minutes ago |
| MACD: Sell Signal | 10:27 AM | 51 minutes ago |
| SMA: Bearish | 10:26 AM | 52 minutes ago |
| SMA: Bearish | 10:25 AM | 53 minutes ago |
| SMA: Bullish | 10:21 AM | 57 minutes ago |
| MACD: Buy Signal | 10:09 AM | 1 hour ago |
Key statistics
- Market cap
- 1.57B
- Enterprise value
- 2.29B
- Trailing P/E
- 15.94
- Forward P/E
- 10.07
- PEG ratio
- 1.68
- Price / sales
- 1.04
- Price / book
- 4.08
- EPS (TTM)
- 2.43
- Beta
- 0.40
- Dividend yield
- 1.23%
- Payout ratio
- 19.75%
- Profit margin
- 6.57%
- Revenue (TTM)
- 1.52B
- Revenue growth
- 4.80%
- Free cash flow
- -19.30M
- Total cash
- 83.98M
- Total debt
- 795.65M
- Return on equity
- 29.72%
- Shares outstanding
- 21.11M
- Short % of float
- 7.09%
- 50-day average
- 36.99
- 200-day average
- 41.26
Analyst view
- Target (low)
- 37.00
- Target (mean)
- 47.00
- Target (high)
- 55.00
- Strong buy1
- Buy0
- Hold2
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 0.78267.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 0.783 | — | — | — |
| Aug 26, 2026 | Jun 30, 2026 | 0.713 | 0.85 | +0.14 | +19.21% |
| May 6, 2026 | Mar 31, 2026 | 0.72 | 0.76 | +0.04 | +5.56% |
| Feb 4, 2026 | Dec 31, 2025 | 0.69 | 0.87 | +0.18 | +26.09% |
| Nov 5, 2025 | Sep 30, 2025 | 0.59 | 0.73 | +0.14 | +23.73% |
| Aug 27, 2025 | Jun 30, 2025 | 0.52 | 0.57 | +0.05 | +9.62% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 14, 2026 | Citigroup | main | Neutral | Neutral |
| Apr 15, 2026 | Citigroup | init | — | Neutral |
| Nov 7, 2025 | JP Morgan | main | Overweight | Overweight |
| Aug 29, 2025 | B of A Securities | main | Underperform | Underperform |
| Jul 7, 2025 | JP Morgan | up | Neutral | Overweight |
| Jun 25, 2025 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
About Phibro Animal Health Corporation
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- pahc.com
News
- Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results
- Will Phibro (PAHC) Beat Estimates Again in Its Next Earnings Report?
- PAHC or SYK: Which Is the Better Value Stock Right Now?
- PAHC vs. HAE: Which Stock Is the Better Value Option?
- Head-To-Head Survey: Tvardi Therapeutics (NASDAQ:TVRD) versus Phibro Animal Health (NASDAQ:PAHC)
- Best Momentum Stocks to Buy for September 21st
- PAHC vs. HAE: Which Stock Should Value Investors Buy Now?
- Phibro Animal Health Corporation $PAHC Shares Acquired by Engineers Gate Manager LP
- 4 Stocks With Strong Interest Coverage to Buy as Yields Rise
- Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term
Your note
Sign in to keep a note on PAHC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANDOLINO ANTHONY | Officer and Treasurer | Stock Award(Grant) | Aug 14, 2025 | 1,793 |
| BENDHEIM DANIEL M | Chief Executive Officer | Stock Award(Grant) | Aug 5, 2026 | 15,177 |
| BENDHEIM JACK C | Officer, Director and Beneficial Owner | Stock Award(Grant) | Aug 5, 2026 | 82,792 |
| BENDHEIM JACK CLIFFORD | Chief Executive Officer | Sale | Apr 29, 2026 | 0 |
| BENDHEIM JONATHAN | Director | Stock Award(Grant) | Aug 5, 2026 | 5,984 |
| CORCORAN E. THOMAS | Director | Purchase | May 28, 2026 | 41,459 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.25% | 3,219,040 | 124.71M | Jun 29, 2026 |
| FMR, LLC | 14.97% | 3,160,281 | 122.43M | Jun 29, 2026 |
| State Street Corporation | 4.92% | 1,038,382 | 40.23M | Jun 29, 2026 |
| Millennium Management Llc | 4.44% | 936,701 | 36.29M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.37% | 923,318 | 35.77M | Jun 29, 2026 |
| Geode Capital Management, LLC | 3.11% | 657,350 | 25.47M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.94% | 1,253,783 | 48.57M | Sep 29, 2026 |
| Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund | 3.75% | 792,401 | 30.70M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.13% | 659,626 | 25.55M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.61% | 551,536 | 21.37M | Sep 29, 2026 |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 1.92% | 405,235 | 15.70M | Aug 30, 2026 |
| LORD ABBETT SECURITIES TRUST-Lord Abbett Value Opportunities Fund | 1.63% | 343,781 | 13.32M | Jul 30, 2026 |